[Personalized urooncology based on molecular uropathology: part 1: what is diagnostic routine?].

about

[Personalized urooncology based on molecular uropathology: part 1: what is diagnostic routine?].

Item

http://www.wikidata.org/entity/Q43765730

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

[Personalized urooncology base ...... what is diagnostic routine?].

@en

[Personalized urooncology base ...... what is diagnostic routine?].

@nl

type

Item

label

[Personalized urooncology base ...... what is diagnostic routine?].

@en

[Personalized urooncology base ...... what is diagnostic routine?].

@nl

prefLabel

[Personalized urooncology base ...... what is diagnostic routine?].

@en

[Personalized urooncology base ...... what is diagnostic routine?].

@nl

P1476

[Personalized urooncology base ...... what is diagnostic routine?].

@en

P2093

A Hartmann

http://www.w3.org/2001/XMLSchema#string

A Rogler

http://www.w3.org/2001/XMLSchema#string

C G Stöhr

http://www.w3.org/2001/XMLSchema#string

K Amann

http://www.w3.org/2001/XMLSchema#string

R Stöhr

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum

Molecular pathways of urothelial development and bladder tumorigenesis.

EAU guidelines on renal cell carcinoma: the 2010 update.

Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful?

Oncogenic FGFR3 gene fusions in bladder cancer.

The application of cytogenetics and fluorescence in situ hybridization to fine-needle aspiration in the diagnosis and subclassification of renal neoplasms.

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.

TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.

No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer.

A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy.

P304

970-975

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00120-013-3228-Z

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ruth Knüchel-Clarke

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23801163

http://www.w3.org/2001/XMLSchema#string